Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

NCT03363945 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplant Rejection

Interventions

BIOLOGICAL: MDR-101

Sponsor

Medeor Therapeutics, Inc.

Collaborators

[object Object]